Aviva PLC Amphastar Pharmaceuticals, Inc. Transaction History

Aviva PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$27.99 - $37.92 $465,641 - $630,837	16,636 Added 71.33%	39,959 $1.5 Million
Q4 2022 Feb 09, 2023	SELL	$27.93 - $31.27 $870,131 - $974,185	-31,154 Reduced 57.19%	23,323 $654,000
Q3 2022 Nov 14, 2022	SELL	$27.56 - $37.75 $62,561 - $85,692	-2,270 Reduced 4.0%	54,477 $1.53 Million
Q2 2022 Aug 04, 2022	BUY	$29.79 - $42.29 $1.69 Million - $2.4 Million	56,747 New	56,747 $1.97 Million

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.